Shanghai Shyndec Pharmaceutical Co., Ltd.

XSSC:600420 주식 보고서

시가총액: CN¥16.4b

Shanghai Shyndec Pharmaceutical 과거 수익 실적

과거 기준 확인 5/6

Shanghai Shyndec Pharmaceutical has been growing earnings at an average annual rate of 7.3%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 0.8% per year. Shanghai Shyndec Pharmaceutical's return on equity is 9%, and it has net margins of 9.4%.

주요 정보

7.3%

수익 성장률

1.5%

EPS 성장률

Pharmaceuticals 산업 성장10.9%
매출 성장률-0.8%
자기자본 수익률9.0%
순이익9.4%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

수익 및 비용 분석

Shanghai Shyndec Pharmaceutical 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

XSSC:600420 수익, 비용 및 수입 (CNY Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 2411,5011,0822,189602
30 Jun 2411,5851,0652,350561
31 Mar 2411,7768442,628573
31 Dec 2312,0706922,888562
30 Sep 2312,4027652,844534
30 Jun 2313,0177483,115522
31 Mar 2313,1327293,263511
31 Dec 2212,9596283,397517
30 Sep 2212,9543633,689559
30 Jun 2212,7003673,872579
31 Mar 2213,2604254,012576
31 Dec 2113,9455684,245585
30 Sep 2113,9036494,427571
30 Jun 2113,9777484,333544
31 Mar 2113,1827344,237542
31 Dec 2012,5566494,075494
30 Sep 2012,5387133,932459
30 Jun 2012,1566114,044437
31 Mar 2012,3286074,200419
31 Dec 1912,1996564,275413
30 Sep 1911,8607034,438368
30 Jun 1911,7236674,331365
31 Mar 1911,3867174,131361
31 Dec 1811,3217063,935371
30 Sep 1810,4166473,605372
30 Jun 189,7915693,019491
31 Mar 189,2605302,588398
31 Dec 178,5185162,106316
30 Sep 179,0865391,904211
30 Jun 179,1245441,9860
31 Mar 179,3245341,9590
31 Dec 169,1264771,9230
30 Sep 1613,5147732,3610
30 Jun 1612,1266972,1590
31 Mar 1610,3885801,9460
31 Dec 158,9885301,7040
30 Sep 152,8292069370
30 Jun 152,8202119130
31 Mar 152,8822039300
31 Dec 142,7491909220
30 Sep 142,4921698520
30 Jun 142,4421598060
31 Mar 142,3171377820
31 Dec 132,3501337400

양질의 수익: 600420 has high quality earnings.

이익 마진 증가: 600420's current net profit margins (9.4%) are higher than last year (6.2%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: 600420's earnings have grown by 7.3% per year over the past 5 years.

성장 가속화: 600420's earnings growth over the past year (41.4%) exceeds its 5-year average (7.3% per year).

수익 대 산업: 600420 earnings growth over the past year (41.4%) exceeded the Pharmaceuticals industry -1.2%.

자기자본 수익률

높은 ROE: 600420's Return on Equity (9%) is considered low.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

7D

1Y

7D

1Y

7D

1Y